Background Although the BNT162b2 COVID-19 vaccine is known to induce IgG neutralizing
antibodies in serum protecting against COVID-19, it has not been studied in detail whether it …

Objectives: Summarize the epidemiology of ocular manifestations of COVID-19. Describe
the typical presentation of a patient with ocular manifestations of COVID-19. Outline …

Background: Growing evidence suggests an association between the infection from the
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and eye disorders. The aim …

Coronaviruses are important human and animal pathogens. At the end of 2019, a novel
coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in …

Purpose This review aims to outline current practices and guidelines of corneal donation
and eye banking, describes the implications of COVID-19 and emerging diseases on the …

Purpose To describe the association between Sars-CoV-2 infection and small fiber
neuropathy in the cornea identified by in vivo corneal confocal microscopy. Methods Twenty …

Background To date, only a few studies reported data regarding the development of
mucosal immune response after the BNT162b2-booster vaccination. Methods Samples of …

Two doses of BNT162b2 mRNA vaccine induces a strong systemic SARS-CoV-2 specific
humoral response. However, SARS-CoV-2 airborne transmission makes mucosal immune …

Background We investigated the ocular surface disturbances in COVID‐19 patients
discharged from the hospital. Methods One hundred and seventy‐nine eyes of 109 healthy …

Despite the reported low expression of the primary SARS-CoV-2 receptor ACE2 in distinct
ocular tissues, some clinical evidence suggests that SARS-CoV-2 can infect the eye. In this …